The Beckley Foundation and its founder and long-time psychedelics researcher Amanda Feilding announced a new research program involving a pioneering study with King's College London and UCL on the ...

Two recent studies conducted by scientists at the University Health Network and the University of Toronto provide new evidence regarding the effects of lysergic acid diethylamide (LSD) on the brain.

NORTH CHARLESTON, S.C. (WCIV) — A new clinical trial underway in the Lowcountry is drawing attention for its unconventional, and potentially groundbreaking, approach to treating anxiety. Researchers ...

LSD usage is on the rise among U.S. adults – especially young adults with depression. And the trend mirrors growing research into the psychedelic drug's ability to treat mental health disorders like ...

A growing body of neuroscience research is converging on a counterintuitive idea: the disorderly brain activity triggered by LSD might actually work against the hyper-synchronized neural firing that ...

A clinical trial’s encouraging results won US Food and Drug Administration breakthrough therapy status for an LSD formulation to treat generalized anxiety disorder, Mind Medicine Inc. announced ...

A series of three new research projects announced this week will seek to illuminate our understanding of microdosing LSD. The research is being spearheaded by The Beckley Foundation and its founder, ...

A New York-based biotech firm has begun a clinical trial to study LSD as a treatment for anxiety, announcing last week that it had administered the psychedelic drug to a patient enrolled in the study ...

Move over Xanax, Prozac, and Duloxetine? A recent study comparing a single oral dose of MM120 (LSD) with a placebo suggests that LSD may be an effective treatment for anxiety. Lysergic acid ...